US3847471014
© PR Newswire
15.12.2025
GRAL
LISTED
NASDAQ
GRAIL to Present at the 44th Annual J.P. Morgan Healthcare Conference
News Preview
MENLO PARK, Calif., Dec. 15, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on Monday, Jan. 12 at 7:30 a.m. PT. ...
Themefolio
Profiler
Peergroup
© PR Newswire
01.12.2025
GRAL
LISTED
NASDAQ
GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
News Preview
MENLO PARK, Calif., Dec. 1, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that it has granted equity awards in the form of restricted stock units ("RSUs") underlying an aggregate of 21,570 shares of GRAIL's common stock to 21 recently hired non-ex...
Themefolio
Profiler
Peergroup
© PR Newswire
18.11.2025
GRAL
LISTED
NASDAQ
GRAIL to Present at Piper Sandler 37th Annual Healthcare Conference
News Preview
MENLO PARK, Calif., Nov. 18, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will present at the Piper Sandler 37th Annual Healthcare Conference on Tuesday, Dec. 2 at 3:00 p.m. ET. ...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© PR Newswire
12.11.2025
GRAL
LISTED
NASDAQ
GRAIL Reports Third Quarter 2025 Financial Results
News Preview
Q3 U.S. Galleri Revenue Grew
28%
Year-Over-Year to
$32.6 Million
Q3 Galleri Tests Sold Grew 39% Year-Ove...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© PR Newswire
04.11.2025
GRAL
LISTED
NASDAQ
GRAIL to Present at 7th Annual Wolfe Research Healthcare Conference
News Preview
MENLO PARK, Calif., Nov. 4, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will present at the 7th Annual Wolfe Research Healthcare Conference on Tuesday, Nov. 18 at 10:00 a.m. ET. ...
Themefolio
Profiler
Peergroup
© PR Newswire
29.10.2025
GRAL
LISTED
NASDAQ
GRAIL to Announce Third Quarter 2025 Financial Results
News Preview
Analyst Day 2025 Webcast to Begin at 11:00 a.m. ET on November 13th
MENLO PARK, Calif., Oct. 29, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be...
Themefolio
Profiler
Peergroup
© PR Newswire
20.10.2025
GRAL
LISTED
NASDAQ
GRAIL, Inc. Announces $325.0 Million Private Placement Financing
News Preview
MENLO PARK, Calif., Oct. 20, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that it has entered into a securities purchase agreement for a private placement that is expected to result in gross proceeds of approxim...
Themefolio
Profiler
Peergroup
© PR Newswire
20.10.2025
GRAL
LISTED
NASDAQ
GRAIL and University of Oxford to Present Long-Term Data From the SYMPLIFY Study Evaluating the Galleri® Multi-Cancer Early Detection Test in Symptomatic Individuals at the Early Detection of Cancer Conference (EDCC)
News Preview
One-Third of Participants Initially Believed to Have a False-Positive Result Were Later Diagnosed With Cancer During Follow Up
Updated Positive Predictive Value of Galleri in This Symptomatic Populati...
Themefolio
Profiler
Peergroup
© PR Newswire
18.10.2025
GRAL
LISTED
NASDAQ
GRAIL PATHFINDER 2 Results Show Galleri ® Multi-Cancer Early Detection Blood Test Increased Cancer Detection More Than Seven-Fold When Added to USPSTF A and B Recommended Screenings
News Preview
More Than Half of Cancers Detected by Galleri Were Early Stage
Approximately Three-Quarters of Galleri-Detected Cancers Do Not Have Recommended Screenings...
Themefolio
Profiler
Peergroup
© PR Newswire
16.10.2025
GRAL
LISTED
NASDAQ
Samsung and GRAIL Announce Strategic Collaboration to Bring GRAIL's Galleri® Multi-Cancer Early Detection Test to Asia
News Preview
Samsung C&T and Samsung Electronics Will Make an Equity Investment of $110 Million Into GRAIL, Subject to Closing Conditions
Samsung C&T Will Drive Commercialization of Galleri in South Korea W...
Themefolio
Profiler
Peergroup
© PR Newswire
23.09.2025
GRAL
LISTED
NASDAQ
GRAIL to Present New Galleri® Data From More Than 32,000 Participants Across the PATHFINDER 2, SYMPLIFY and REFLECTION Studies at ESMO Congress 2025 and EDCC
News Preview
First PATHFINDER 2 Results Accepted as a Late-Breaking Presentation at the European Society for Medical Oncology (ESMO) Congress 2025; Results to be Submitted to FDA as Part of the Galleri Premarket Approval Application (PMA)
Updated SYMPLIFY and REFLECTION Study Results to be Presented at the Early Detection of Cancer Conference (EDCC) Highligh...
Themefolio
Profiler
Peergroup
© PR Newswire
10.09.2025
GRAL
LISTED
NASDAQ
GRAIL to Present at Bernstein Insights: Healthcare Leaders and Disruptors - 2nd Annual Healthcare Forum
News Preview
MENLO PARK, Calif., Sept. 10, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will present at Bernstein Insights: Healthcare Leaders and Disruptors – 2nd Annual Healthcare Forum on Wednesday, Sep. 24 at 8:00 a.m. ET. ...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© PR Newswire
26.08.2025
GRAL
LISTED
NASDAQ
GRAIL to Present at Morgan Stanley 23rd Annual Global Healthcare Conference
News Preview
MENLO PARK, Calif., Aug. 26, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will present at the Morgan Stanley 23rd Annual Global Healthcare Conference on Tuesday, Sep. 9 at 1:50 p.m. ET. ...
Themefolio
Profiler
Peergroup
© PR Newswire
12.08.2025
GRAL
LISTED
NASDAQ
GRAIL Reports Second Quarter 2025 Financial Results
News Preview
Q2 U.S. Galleri Revenue Grew 21% Year-Over-Year to $34.2 Million
Q2 Galleri Tests Sold Grew 29% Year-Over-Year to More Than 45,000
Detailed Results From First 25,000 Enrolled in PATHFINDER 2 to be Submitted for Presentation at ESMO 2025 in October
MENLO PARK, Calif., Aug. 12, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company w...
Themefolio
Profiler
Peergroup
© PR Newswire
30.07.2025
GRAL
LISTED
NASDAQ
GRAIL to Present at Canaccord Genuity 45th Annual Growth Conference
News Preview
MENLO PARK, Calif., July 30, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will present at the Canaccord Genuity 45th Annual Growth Conference in Boston on Wednesday, Aug. 13 at 8:30 a.m. ET. ...
Themefolio
Profiler
Peergroup
© PR Newswire
29.07.2025
GRAL
LISTED
NASDAQ
GRAIL to Announce Second Quarter 2025 Financial Results
News Preview
MENLO PARK, Calif., July 29, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, announced today that it will issue financial results for the second quarter 2025 following the close of market on Tuesday, Aug. 12, 2025. Following the release, company management will ho...
Themefolio
Profiler
Peergroup
© PR Newswire
18.06.2025
GRAL
LISTED
NASDAQ
GRAIL Announces Positive Top-Line Results From The Galleri® PATHFINDER 2 Registrational Study
News Preview
Cancer Detection and Positive Predictive Value Substantially Higher Than the Previously Published PATHFINDER Study
MENLO PARK, Calif., June 18, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced positive top-line performance and safety results from th...
Themefolio
Profiler
Peergroup
© PR Newswire
30.05.2025
GRAL
LISTED
NASDAQ
GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
News Preview
MENLO PARK, Calif., May 30, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that it has granted equity awards in the form of restricted stock units ("RSUs") underlying an aggregate of 77,350 shares of GRAIL's common stock to 38 recently hired non-e...
Themefolio
Profiler
Peergroup
© PR Newswire
21.05.2025
GRAL
LISTED
NASDAQ
GRAIL to Present at Jefferies Global Healthcare Conference 2025
News Preview
MENLO PARK, Calif., May 21, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will present at the Jefferies Global Healthcare Conference 2025 in New York on Tuesday, June 4 at 11:40 a.m. ET. ...
Themefolio
Profiler
Peergroup
© PR Newswire
13.05.2025
GRAL
LISTED
NASDAQ
GRAIL Reports First Quarter 2025 Financial Results
News Preview
Q1 U.S. Galleri Revenue Grew 22% Year-Over-Year to $28.7 Million
GRAIL Announces Positive Top-Line Results From the Prevalent Screening Round of the NHS-Galleri Trial
Cash Position of $677.9 Million Provides Runway Into 2028
MENLO PARK, Calif., May 13, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detec...
Themefolio
Profiler
Peergroup
© PR Newswire
12.05.2025
GRAL
LISTED
NASDAQ
GRAIL and athenahealth Team Up to Offer Healthcare Providers Streamlined Ordering of GRAIL's Galleri® Multi-Cancer Early Detection (MCED) Test
News Preview
MENLO PARK, Calif., May 12, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced a new partnership with athenahealth, a leading provider of network-enabled software and services for healthcare practices and systems nationwide. This collaboration will in...
Themefolio
Profiler
Peergroup
© PR Newswire
29.04.2025
GRAL
LISTED
NASDAQ
GRAIL to Announce First Quarter 2025 Financial Results
News Preview
MENLO PARK, Calif., April 29, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, announced today that it will issue financial results for the first quarter 2025 following the close of market on Tuesday, May 13, 2025. Following the release, company management will hos...
Themefolio
Profiler
Peergroup
© PR Newswire
22.04.2025
GRAL
LISTED
NASDAQ
GRAIL to Present New Data on Galleri® and its Methylation Platform at American Association for Cancer Research (AACR) Annual Meeting
News Preview
Real-World Data in 100,000 Patients Further Support the Galleri® Test's Ability to Simultaneously Screen for Multiple Cancers, as Well as its Accuracy of Cancer Signal of Origin Prediction to Support More Efficient Diagnostic Evaluations
Data From GRAIL's ctDNA-based Targeted Methylation Assay Highlight Potential to Identify Robust Signals of Pr...
Themefolio
Profiler
Peergroup
© PR Newswire
26.02.2025
GRAL
LISTED
NASDAQ
GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
News Preview
MENLO PARK, Calif., Feb. 26, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that it has granted equity awards in the form of restricted stock units ("RSUs") underlying an aggregate of 108,450 shares of GRAIL's common stock to 15 recently hired non...
Themefolio
Profiler
Peergroup
© PR Newswire
25.02.2025
GRAL
LISTED
NASDAQ
GRAIL Partners With Actress Kate Walsh for Generation Possible to Raise Awareness of Multi-Cancer Early Detection Testing
News Preview
MENLO PARK, Calif., Feb. 25, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL) a healthcare company whose mission is to detect cancer early when it can be cured, has partnered with award-winning actress Kate Walsh to launch Generation Possible, an educational initiative to raise awareness of multi-cancer early detection (MCED) testing. Generation P...
Themefolio
Profiler
Peergroup
© PR Newswire
21.02.2025
GRAL
LISTED
NASDAQ
GRAIL to Present at TD Cowen 45th Annual Health Care Conference
News Preview
MENLO PARK, Calif., Feb. 21, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will present at the TD Cowen 45th Annual Health Care Conference in Boston on Tuesday, Mar. 4 at 9:10 a.m. ET. ...
Themefolio
Profiler
Peergroup
© PR Newswire
20.02.2025
GRAL
LISTED
NASDAQ
GRAIL Reports Fourth Quarter and Full Year 2024 Financial Results
News Preview
Sold More than 137,000 Galleri® Tests in 2024, Growing U.S. Galleri Revenue 45% Year-Over-Year to $108.6 Million
Completed Study Visits for Two Registrational Studies in July to Support Modular PMA Submission for Galleri
On Track for Continued Commercial Growth in 2025 with TRICARE Coverage and Recent Announcement of Quest Integration
Moderated...
Themefolio
Profiler
Peergroup
© PR Newswire
12.02.2025
GRAL
LISTED
NASDAQ
GRAIL to Announce Fourth Quarter 2024 Financial Results
News Preview
MENLO PARK, Calif., Feb. 12, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, announced today that it will issue financial results for the fourth quarter 2024 following the close of market on Thursday, Feb. 20, 2025. Following the release, company management will h...
Themefolio
Profiler
Peergroup
© PR Newswire
12.02.2025
GRAL
LISTED
NASDAQ
GRAIL and Quest Diagnostics Provide GRAIL's Galleri® Multi-Cancer Early Detection (MCED) Test Through the Quest Diagnostics Test Ordering System
News Preview
GRAIL's Galleri Test Now Directly Available to Physicians in the U.S. Through Collaboration With Quest Diagnostics, Delivering a More Streamlined Provider and Patient Experience
MENLO PARK, Calif. and SECAUCUS, N.J., Feb. 12, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can...
Themefolio
Profiler
Peergroup
© PR Newswire
14.01.2025
GRAL
LISTED
NASDAQ
Patient Reported Outcomes for GRAIL's Galleri® Multi-Cancer Early Detection Blood Test Published in Lancet Oncology
News Preview
Analysis of Patient Reported Outcomes From PATHFINDER Indicate Minimal Patient Distress Associated with Multi-Cancer Early Detection Testing
MENLO PARK, Calif., Jan. 13, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL) a healthcare company whose mission is to detect cancer early when it can be cured, today announced that patient-reported outcomes...
Themefolio
Profiler
Peergroup
© PR Newswire
18.12.2024
GRAL
LISTED
NASDAQ
GRAIL to Present at the 43rd Annual J.P. Morgan Healthcare Conference
News Preview
MENLO PARK, Calif., Dec. 18, 2024 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will present at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, Jan. 15 at 9:00 a.m. PT. ...
Themefolio
Profiler
Peergroup
© PR Newswire
03.12.2024
GRAL
LISTED
NASDAQ
GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
News Preview
MENLO PARK, Calif., Dec. 3, 2024 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that it has granted equity awards in the form of restricted stock units ("RSUs") underlying an aggregate of 115,093 shares of GRAIL's common stock to 46 recently hired non-...
Themefolio
Profiler
Peergroup
© PR Newswire
19.11.2024
GRAL
LISTED
NASDAQ
GRAIL to Participate in Upcoming Investor Conferences
News Preview
MENLO PARK, Calif., Nov. 19, 2024 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will participate in the following investor conferences....
Themefolio
Profiler
Peergroup
© PR Newswire
18.11.2024
GRAL
LISTED
NASDAQ
GRAIL Announces First Patient Tested With Blood-Based Assay in Global Phase 3 Adjuvant Lung Cancer Study
News Preview
MENLO PARK, Calif., Nov. 18, 2024 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that the first patient has been tested for eligibility with the investigational GRAIL Non-Small Cell Lung Cancer (NSCLC) ctDNA Assay in the global TROPION-Lung12 Phase 3...
Themefolio
Profiler
Peergroup
© PR Newswire
12.11.2024
GRAL
LISTED
NASDAQ
GRAIL Reports Third Quarter 2024 Financial Results
News Preview
Galleri Revenue Grew 52% Year-Over-Year to $25.4 Million
Commercial Galleri Sales Surpassed 250,000 Tests Since Launch
Cash Balance of $853.6 Million Provides Runway Into 2028
MENLO PARK, Calif., Nov. 12, 2024 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today repor...
Themefolio
Profiler
Peergroup
© PR Newswire
04.11.2024
GRAL
LISTED
NASDAQ
GRAIL to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
News Preview
MENLO PARK, Calif., Nov. 4, 2024 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum in New York on Thursday, Nov. 21 at 11:00 a.m. ET...
Themefolio
Profiler
Peergroup
© PR Newswire
29.10.2024
GRAL
LISTED
NASDAQ
GRAIL to Announce Third Quarter 2024 Financial Results
News Preview
MENLO PARK, Calif., Oct. 29, 2024 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, announced today that it will issue financial results for the third quarter 2024 following the close of market on Tuesday, Nov. 12, 2024. Following the release, company management will hos...
Themefolio
Profiler
Peergroup
© PR Newswire
24.10.2024
GRAL
LISTED
NASDAQ
GRAIL Presents Initial Results From REFLECTION Real-World Evidence Study of Galleri® Multi-Cancer Early Detection (MCED) Test at the Early Detection of Cancer Conference
News Preview
Study Participants from Veteran Affairs Sites Include a Diverse Population With Toxic Exposure
MENLO PARK, Calif., Oct. 23, 2024 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced early results from the REFLECTION study, which aims to understand the real-...
Themefolio
Profiler
Peergroup
© PR Newswire
21.10.2024
GRAL
LISTED
NASDAQ
GRAIL Appoints Sarah Krevans to Board of Directors
News Preview
MENLO PARK, Calif., Oct. 21, 2024 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced the appointment of Sarah Krevans to its Board of Directors, effective immediately. Ms. Krevans will also serve as a member of the Board's Audit Committee, Compensation Com...
Themefolio
Profiler
Peergroup
© PR Newswire
30.08.2024
GRAL
LISTED
NASDAQ
GRAIL ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(c)(4)
News Preview
MENLO PARK, Calif., Aug. 30, 2024 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that it has granted equity awards in the form of restricted stock units ("RSUs") underlying an aggregate of 182,223 shares of GRAIL's common stock to 55 recently hired non-e...
Themefolio
Profiler
Peergroup
© PR Newswire
29.08.2024
GRAL
LISTED
NASDAQ
Results of GRAIL's Galleri® Multi-Cancer Early Detection Blood Test in Prostate Cancer Published in JCO Precision Oncology
News Preview
Data Support Clinical Performance of Galleri to Detect More Aggressive Prostate Cancers
MENLO PARK, Calif., Aug. 29, 2024 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL) a healthcare company whose mission is to detect cancer early when it can be cured, today announced that detailed findings of the performance of its Galleri® multi-cancer early detect...
Themefolio
Profiler
Peergroup
© PR Newswire
21.08.2024
GRAL
LISTED
NASDAQ
GRAIL to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
News Preview
MENLO PARK, Calif., Aug. 21, 2024 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will present at the Morgan Stanley 22nd Annual Global Healthcare Conference at 3:20 p.m. ET on Sept. 4, 2024....
Themefolio
Profiler
Peergroup
© PR Newswire
13.08.2024
GRAL
LISTED
NASDAQ
GRAIL Reports Second Quarter 2024 Financial Results and Provides a Strategic Update
News Preview
Second Quarter Revenue Grew 43% Year-Over-Year to $32.0 Million
Portfolio Prioritization and Corporate Restructure Extends Cash Runway into 2028
MENLO PARK, Calif., Aug. 13, 2024 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today reported business and financial resu...
Themefolio
Profiler
Peergroup
© PR Newswire
08.08.2024
GRAL
LISTED
NASDAQ
Wheels Up Announces Gregory Summe to Join Board of Directors
News Preview
Veteran Leader Brings Deep Strategic, Aviation, and Governance Experience to Boardroom
ATLANTA, Aug. 8, 2024 /PRNewswire/ -- Wheels Up Experience Inc. (NYSE: UP) today announced that Gregory L. Summe, Managing Partner of Glen Capital Partners LLC, joined its Board of Directors, effective August 7....
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
